Nerve Fiber Density Testing
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Oklahoma Policy CPCPLABO64 alerts
Get alerted when Policy CPCPLABO64 changes without checking for updates manually.
Monitor payer policy activity
This policy governs reimbursement criteria for epidermal nerve fiber density measurement (skin biopsy) for diagnosis of small-fiber neuropathy for Blue Cross Blue Shield of Oklahoma members and providers.
Document updated with literature review; Reimbursement Information unchanged; References revised.
Reimbursement Information revised for clarity and code list updated: added code 88313; removed codes 88305 and 88314.
New policy established on 11/01/2022.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.